UNSPSC 85814913: Introduction of monoclonal antibody into male reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into male reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0N30M

UNSPSC 85814913 Introduction of monoclonal antibody into male reproductive, percutaneous approach is a Commodity code representing a highly specialized medical procedure within urology and reproductive medicine. The code's nominal title does not align with the recent state and local procurement activity tagged under it; the opportunities posted against this code involve telehealth urgent care, medical services, comprehensive elderly care programming, cancer registry services, medical director oversight, occupational health screening, employee wellness platforms, opioid use disorder treatment, youth behavioral health crisis services, and inmate healthcare — none of which involve monoclonal antibody introduction or male reproductive interventions. The mismatch between code designation and actual purchasing scope signals that this code shows little relevant recent activity in state and local procurement. Issuing bodies across the opportunities span regional health authorities (Nevada Health Authority), county health systems (Santa Clara, Ventura, Solano, Rockland, Jackson, DeKalb), municipal departments (City of Ocala, City of Phoenix, City of Atlanta, Seminole County), school districts (Parkway School District), and specialized purchasing consortia (Sourcewell, H-GAC, Region 7). The geographic spread is broad and national, with activity concentrated in California (San Mateo, Ventura, Santa Clara), Nevada, Colorado, Georgia (Cobb, DeKalb, Forsyth), Florida (Sarasota, Seminole, Marion/Ocala), Texas, Kansas (Sedgwick/Wichita), Virginia (Fairfax, Alexandria), and scattered instances in other states.

The recent opportunities under this code are representative of state and local health and behavioral health service delivery rather than pharmaceutical or procedural interventions. Inland Empire Health Plan (IEHP) issued an RFI on October 16, 2026, closing October 31, 2026, seeking virtual urgent care services through California board-certified physicians offering 24/7/365 telehealth evaluation and prescriptive authority. The Nevada Health Authority posted an RFP on October 8, 2026, for Program of All Inclusive Care for the Elderly (PACE) operations across Nevada (due December 10, 2026), structured as a fixed-capitation model at $4,532–$8,804 monthly per participant across Clark County, Washoe County, and rural service areas, with service commencement targeted for State Fiscal Year 2028–2029. The San Mateo County Medical Center issued RFPs in October 2026 for cancer registry services (due November 6, 2026) and handheld retinal screening devices with integrated EPIC connectivity and 24/7 technical support (due November 6, 2026), both with three-year terms and local business preferences. The City of Phoenix issued a substantial cancer screening services RFP (due February 2, 2026, with anticipated contract value up to $3.5 million annually, commencing July 1, 2027) and an employee wellness portal procurement (due May 22, 2026) for enterprise health risk assessment and platform administration. The Texas Health and Human Services Commission and county health systems across multiple states have posted occupational health screening, recovery audit contracting, and substance use disorder treatment and prevention services. This code's tagging appears to be a data quality issue in the source system rather than a signal of genuine procurement demand in the specialty area the code nominally describes.